MGLL, monoglyceride lipase, 11343

N. diseases: 125; N. variants: 7
Disease: Malignant Bone Neoplasm ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0279530
Disease: Malignant Bone Neoplasm
Malignant Bone Neoplasm 		0.010 Biomarker disease BEFREE MAGL inhibitors such as JZL184, or its novel analogues, may be of value in the treatment of bone disease caused by primary bone cancer and bone metastasis, however, activation of the skeletal endocannabinoid system may limit their usefulness as osteoprotective agents. 31151929 2019